STOCK TITAN

Super Group (SGHC) Limited Form 4 Filings

SGHC NYSE

Every Form 4 that Super Group (SGHC) Limited (SGHC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SGHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SGHC filings page.

Rhea-AI Summary

Super Group (SGHC) Ltd reported that Chief Technology Officer Ben David Alon sold 23,300 shares of common stock on September 14, 2026 in a sale described as occurring in an open market or private transaction at $13.79 per share.

After this transaction, he directly holds 7,814 shares of Super Group common stock, and no Rule 10b5-1 trading plan is reported for this sale.

Rhea-AI Summary

Super Group (SGHC) Ltd (SGHC) Chief Operating Officer Kirsty Farrah Ross reported a sale of 40,000 shares of common stock on 2026-08-28 in an open market or private transaction at $14.00 per share. After this transaction, Ross directly holds 48,261 shares of Super Group common stock. The filing’s Rule 10b5-1 checkbox was not marked as being pursuant to a trading plan.

Rhea-AI Summary

Super Group (SGHC) Ltd reported that Chief Financial Officer Alinda Van Wyk had 50,210 restricted stock units (RSUs) vest and settle into an equal number of common shares on July 31, 2026, following an amendment to the company’s global LTIP vesting schedule.

In connection with this partial vesting, she sold 22,644 shares at $13.97 per share solely to satisfy tax withholding obligations. From the original 150,632 RSU grant on March 1, 2025, 100,422 RSUs remain and are scheduled to vest in two equal installments on March 31, 2027 and March 31, 2028.

Rhea-AI Summary

Super Group (SGHC) Ltd CEO Neal Menashe had 102,839 RSUs from a March 1, 2025 grant settle into common stock on July 31, 2026. He then sold 48,440 shares at $13.97 solely to satisfy tax withholding obligations and retains 205,679 RSUs vesting in 2027 and 2028.

Rhea-AI Summary

Super Group (SGHC) Ltd reported that Chief Operating Officer Kirsty Farrah Ross settled 115,812 RSUs into common stock on July 31, 2026, from prior grants. On the same date she sold 54,551 shares at $13.97 per share, described as solely to cover tax withholding obligations. From a 107,437-unit grant, 35,812 RSUs vested on July 31, 2026, with the remainder scheduled to vest in equal installments on March 31, 2027 and March 31, 2028.

Rhea-AI Summary

Super Group (SGHC) Ltd’s general counsel reported the vesting and settlement of 8,817 Restricted Stock Units (RSUs) into common stock on July 31, 2026, from a 26,453‑unit grant whose vesting schedule was amended. Of the shares received, 3,997 were sold at $13.97 per share solely to cover tax withholding, with the remaining shares retained. 17,636 RSUs continue to vest in two equal installments on March 31, 2027 and March 31, 2028, payable one‑for‑one in shares or cash at the issuer’s election.

Rhea-AI Summary

Super Group (SGHC) Ltd’s Chief Technology Officer, Ben David Alon, reported routine equity compensation activity. On June 12, 2026, he was granted 116,747 restricted stock units (RSUs). Of these, 38,915 RSUs were settled into common stock on June 30, 2026.

On the same date, he sold 7,801 shares of common stock at $13.74 per share solely to cover tax withholding obligations from the RSU vesting. After these transactions, he held 31,114 shares of common stock directly and 77,832 RSUs scheduled to vest in equal installments on March 31, 2027 and March 31, 2028.

Rhea-AI Summary

Ben David Alon reported acquisition or exercise transactions in this Form 4 filing.

Super Group (SGHC) Ltd granted its Chief Technology Officer, Ben David Alon, two equity awards in the form of restricted stock units (RSUs) on June 12, 2026. Each award covers 116,747 RSUs, representing compensation rather than open-market share purchases or sales.

The first RSU grant vests in three tranches of 38,915, 38,916, and 38,916 shares on June 30, 2026, March 31, 2027, and March 31, 2028. The second grant vests in three annual tranches of 58,373, 29,187, and 29,187 shares on March 31, 2029, March 31, 2030, and March 31, 2031. Upon vesting, each RSU will be settled one-for-one in common stock or in cash, at the company’s election.

Rhea-AI Summary

Super Group (SGHC) Ltd’s Chief Operating Officer, Kirsty Farrah Ross, reported an open-market sale of Common Stock. On June 2, 2026, she sold 25,356 shares at $13.00 per share. After this transaction, she directly holds 27,000 shares of the company’s common stock.

Rhea-AI Summary

Super Group (SGHC) Ltd Chief Financial Officer Alinda Van Wyk reported an open-market sale of 78,837 shares of Common Stock on May 19, 2026 at a price of $13.70 per share. Following this transaction, the filing shows 0 shares of this security held directly.

Rhea-AI Summary

Super Group (SGHC) Ltd Chief Operating Officer Kirsty Farrah Ross sold 44,628 shares of common stock in an open-market sale. The transaction occurred on May 15, 2026 at an average price of $13.03 per share. After this sale, she directly holds 52,356 shares.

Rhea-AI Summary

Super Group (SGHC) Ltd’s General Counsel Nathan Martine reported compensation-related equity moves and a small share sale. On March 31, 2026, RSUs previously granted in 2025 and 2026 vested and were settled into a total of 10,465 shares of common stock at a conversion price of $0.00 per share, increasing her direct holdings.

After these settlements, she held 34,933 common shares and had 8,800 RSUs from the 2026 grant and 6,066 RSUs from the 2025 grant still outstanding, scheduled to vest in 2027 and 2028. On April 8, 2026, Martine sold 4,761 common shares at $10.71 each, with the footnotes stating the sale was made solely to cover tax withholding obligations arising from the RSU vesting. Following this tax-related sale, she directly owned 30,172 common shares, alongside her remaining unvested RSUs.

Rhea-AI Summary

Super Group (SGHC) Ltd Chief of Staff Kirsty Farrah Ross reported equity compensation activity and related share sales. On March 31, 2026, RSUs previously granted to her were settled into common stock, and she acquired additional shares through derivative exercises. She then sold 47,391 shares of common stock at $10.71 per share on April 8, 2026, with a footnote stating the sale was made solely to cover tax withholding obligations arising from RSU vesting. Following these transactions, she directly holds 96,984 common shares, indicating the filing reflects routine compensation vesting with a tax-related share sale rather than a discretionary reduction of her position.

Rhea-AI Summary

Super Group (SGHC) Ltd Chief Financial Officer Alinda Van Wyk settled multiple restricted stock unit (RSU) awards into common stock and sold shares to cover taxes. On March 31, 2026, 16,150, 48,649 and 47,543 RSUs were settled on a one-for-one basis into common stock. On April 8, 2026, she sold 51,104 common shares at $10.71 per share solely to satisfy tax withholding obligations related to the RSU vesting. After these transactions, she directly holds 78,837 common shares, with additional RSUs scheduled to vest in equal annual installments on March 31, 2027 and March 31, 2028.

Rhea-AI Summary

Super Group (SGHC) Ltd CEO Neal Menashe reported the vesting of restricted stock units and related share movements. On March 31, 2026, several RSU awards vested and were settled on a one-for-one basis into common stock, increasing his direct holdings.

On the same date, he sold 78,530 shares of common stock at $10.71 per share, but a footnote states this sale was made solely to satisfy tax withholding obligations from the RSU vesting, rather than a discretionary open-market sale. After these transactions, he directly owns 676,334 shares of common stock.